Participate in early-phase drug discovery as a chemical biologist. Responsible for developing new assays for a variety of rare diseases and cancer. Interests include target identification/deconvolution, discovery of synergistic drug-drug interactions, emergence of treatment-derived resistance, and clinically informed structural activity relationship(SAR) characterization.

Performed mass spectrometry research in the McLean Lab. Worked with lipidomics data from an Agilent 6560 to explore and build an open-source mass spectrometry data analytics pipeline. Devised, built, and implemented a humidity control mechanism for a Desorption Electrospray Ionization mass spectrometer (DESI-MS). Experience with sample preparation, LC-MS workflow, and DESI-MS workflow. Software Used: Arduino, Python (Packages: Pandas, SciPy, OpenMS), Angular (Typescript, HTML), Autodesk Inventor, and Autodesk CFD analysis.Hardware Used: Electronic fabrication (PCB design, soldering), 3D-printing, and laser cutting.

Developed a sample preparation methodology for tissue mimetics on a Bruker FT-ICR mass spectrometer.